Effects of melperone and thiothixene on prolactin levels in cerebrospinal fluid and plasma of psychotic women.
D000328:Adult; D002090:Butyrophenones / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008875:Middle Aged; D010880:Piperidines / Q000627:therapeutic use; D011388:Prolactin / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism*; D011954:Receptors, Dopamine / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism*; D013375:Substance Withdrawal Syndrome / Q000378:metabolism; D013888:Thiothixene / Q000627:therapeutic use*; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D002090:Butyrophenones; D010880:Piperidines; D011954:Receptors, Dopamine; D014149:Tranquilizing Agents; D013888:Thiothixene; D011388:Prolactin; C008522:metylperon